Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...

Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Stephens analysts adjusted their stance on Paragon 28 , Inc. (NYSE:FNA), downgrading the stock from Overweight to Equal ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.5glegtPn.js ...

William Blair has recently reduced Paragon 28 Inc (FNA) stock to Mkt Perform rating, as announced on Today, according to Finviz. Earlier, on Today, Needham had reduced the stock from a Buy to Hold.

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Paragon 28 Inc (NYSE: FNA) announced its acquisition by Zimmer Biomet (NYSE: ZBH), both rated Market-Outperform by JMP ...

(Reuters) -Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand ...

Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...

Stephens downgraded Paragon 28 (FNA) to Equal Weight from Overweight with a $13 price target after Zimmer Biomet (ZBH) agreed to acquire the ...

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year.

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...